000 -LEADER |
fixed length control field |
01390 a2200277 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
041203s xx 000 0 eng |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1522-323X; |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
AC1.S5 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
050 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Shepherd, Scott T., |
245 #0 - TITLE STATEMENT |
Title |
Not FDA-Approved. |
Statement of responsibility, etc. |
Scott T. Shepherd. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Name of publisher, distributor, etc. |
New Physician, |
Date of publication, distribution, etc. |
2004. |
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
SIRS Enduring Issues 2005. |
Number of part/section of a work |
Article 12, |
Name of part/section of a work |
Health, |
International Standard Serial Number |
1522-323X; |
500 ## - GENERAL NOTE |
General note |
Articles Contained in SIRS Enduring Issues 2005. |
500 ## - GENERAL NOTE |
General note |
Originally Published: Not FDA-Approved, May/June 2004; pp. 12+. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"On a daily basis, pharmaceutical sales and detail reps meet with physicians to discuss their companies' various products. And while they're not allowed to promote an off-label use, they are allowed to dance on the line between promoting and providing information." (NEW PHYSICIAN) This article discusses off-label prescriptions, in which drug prescriptions are written for a use other than what the drug was approved for. |
599 ## - |
-- |
Records created from non-MARC resource. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Effectiveness |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Off-label prescribing |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Side effects |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Testing |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical industry |
610 ## - SUBJECT ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
United States |
Subordinate unit |
Food and Drug Adm. |
710 ## - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
ProQuest Information and Learning Company |
Title of a work |
SIRS Enduring Issues 2005, |
Name of part/section of a work |
Health. |
International Standard Serial Number |
1522-323X; |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
|